Position in CMPX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,819,776
+$4,003,518 QoQ
Shares Held
3,570,674
+395.0% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 213 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CMPX Over Time
Shares Held
Position Value (USD)
Derivatives in CMPX
reported options exposure · as of Jun 30, 2026CallValue
$161,622
CallShares
73,800
PutValue
$143,445
PutShares
65,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. CMPX ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in CMPX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,445 | 65,500 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $7,819,776 | 3,570,674 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $161,622 | 73,800 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $505,195 | 95,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $392,518 | 74,200 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $3,816,258 | 721,410 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $567,512 | 105,682 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $816,448 | 233,271 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,240 | 12,400 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $322,240 | 169,600 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $76,950 | 40,500 | Call | Defined | 2025-05-15 | |
| 2024-09-30 | $118,175 | 64,226 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $267,772 | 267,772 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $285,485 | 144,185 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $259,173 | 166,137 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $145,384 | 44,460 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $313,248 | 62,276 | Shares | Defined | 2023-02-14 | |
| 2021-12-31 | $106,426 | 33,573 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||